{"id":"14c-lazertinib","_chembl":{"chemblId":"CHEMBL4558324","moleculeType":"Small molecule","molecularWeight":"554.66"},"_fixedAt":"2026-03-30T12:04:22.802792","modality":"Small molecule","_dailymed":null,"mechanism":{"modality":"Small Molecule"},"_scrapedAt":"2026-03-28T06:49:33.903Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123336,"model":"claude-sonnet-4-5-20250929"},"description":"14C-lazertinib is a radiolabeled form of lazertinib, an investigational compound being studied by Janssen Research & Development in Phase 1 clinical trials. The radiolabeled version is used in pharmacokinetic and metabolism studies to track the drug's distribution and elimination in the body.","indications":{"approved":[{"status":"investigational","condition":"Pharmacokinetic study","patientPopulation":"Adult subjects"}]},"_fixedFields":["modality→Small Molecule"],"trialDetails":[{"nctId":"NCT04410081","phase":"PHASE1","title":"A Study of (14C)-JNJ-73841937 (Lazertinib) in Healthy Male Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-07-14","conditions":"Healthy","enrollment":8}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["JNJ-73841937"],"phase":"phase_1","status":"active","brandName":"14C-lazertinib","genericName":"14C-lazertinib","companyName":"Janssen Research & Development, LLC","companyId":"johnson-johnson","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}